Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (161-170 of 331) with videos related to

Pageof 34
Sort By:
Molecular Pharmacology|July 28, 2016
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric ModulatorsAlice E Berizzi, Patrick R Gentry, Patricia Rueda, et al.
Current Opinion in Structural Biology|March 17, 2018
Recent advances in the determination of G protein-coupled receptor structuresDavid M Thal, Ziva Vuckovic, Christopher J Draper-Joyce, et al.
ACS Chemical Biology|April 27, 2016
Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric ModulatorsKaren J Gregory, Ranganadh Velagaleti, David M Thal, et al.
Journal of Medicinal Chemistry|December 15, 2015
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric ComplexAditya J Desai, Polo C H Lam, Andrew Orry, et al.
ACS Chemical Neuroscience|December 14, 2021
Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and EfficacyMatthew C L Wakeham, Briana J Davie, David K Chalmers, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
Homology modeling of GPCRsJohn Simms, Nathan E Hall, Polo H C Lam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2008
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosaKylie J Mansfield, Jonathan J Chandran, Kenneth J Vaux, et al.
Bioorganic & Medicinal Chemistry|September 16, 2009
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonistsLuigi Aurelio, Celine Valant, Heidi Figler, et al.
The Journal of Biological Chemistry|August 30, 2008
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligandCeline Valant, Karen J Gregory, Nathan E Hall, et al.
Molecular Pharmacology|June 22, 2023
Role of Conserved Tyrosine Lid Residues in the Activation of the M<sub>2</sub> Muscarinic Acetylcholine ReceptorVi Pham, Maria Clazina Cornelia Habben Jansen, Geoff Thompson, et al.
Pageof 34

Showing results (161-170 of 331) with videos related to

Sort By:
Pageof 34
Molecular Pharmacology|July 28, 2016
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric ModulatorsAlice E Berizzi, Patrick R Gentry, Patricia Rueda, et al.
Current Opinion in Structural Biology|March 17, 2018
Recent advances in the determination of G protein-coupled receptor structuresDavid M Thal, Ziva Vuckovic, Christopher J Draper-Joyce, et al.
ACS Chemical Biology|April 27, 2016
Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric ModulatorsKaren J Gregory, Ranganadh Velagaleti, David M Thal, et al.
Journal of Medicinal Chemistry|December 15, 2015
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric ComplexAditya J Desai, Polo C H Lam, Andrew Orry, et al.
ACS Chemical Neuroscience|December 14, 2021
Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and EfficacyMatthew C L Wakeham, Briana J Davie, David K Chalmers, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
Homology modeling of GPCRsJohn Simms, Nathan E Hall, Polo H C Lam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2008
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosaKylie J Mansfield, Jonathan J Chandran, Kenneth J Vaux, et al.
Bioorganic & Medicinal Chemistry|September 16, 2009
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonistsLuigi Aurelio, Celine Valant, Heidi Figler, et al.
The Journal of Biological Chemistry|August 30, 2008
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligandCeline Valant, Karen J Gregory, Nathan E Hall, et al.
Molecular Pharmacology|June 22, 2023
Role of Conserved Tyrosine Lid Residues in the Activation of the M<sub>2</sub> Muscarinic Acetylcholine ReceptorVi Pham, Maria Clazina Cornelia Habben Jansen, Geoff Thompson, et al.
Pageof 34